Carson Keeter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carson Keeter has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Kyle Jamar
Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO 80045, USA
3 shared publications - Nancy Hadley Miller
Children’s Hospital Colorado, Aurora, CO
3 shared publications - Po-Chih Shen
Department of Orthopaedics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan
3 shared publications - Adam Peszek
Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO 80045, USA
2 shared publications - Caleb J. Wipf
Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO 80045, USA
2 shared publications - Catherine C. Alder
Department of Orthopedics, University of Colorado School of Medicine, Aurora, CO 80045, USA
2 shared publications
Latest Publications
- 29 October 2026
- Published by Wiley in Arthroscopy
Quadriceps Tendon Autograft for Primary Anterior Cruciate Ligament Reconstruction Has No Difference in Short‐Term Clinical Outcomes Between All‐Soft Tissue Versus Tendon–Bone Grafts: A Systematic Review
Purpose: To compare clinical outcomes and complications after primary anterior cruciate ligament reconstruction with all‐soft tissue quadriceps tendon (ST‐QT) versus quadriceps tendon‐bone (QT–B) autograft. Methods: A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines by searching PubMed, Embase, and Cochrane Library to identify studies directly comparing outcomes of primary anterior cruciate ligament reconstruction with ST‐QT versus QT–B autograft. Outcomes included rates of graft failure and other complications, patient‐reported outcomes, return to sport, anteroposterior knee laxity, pivot shift testing, and the Objective International Knee Documentation Committee score. Results: Five studies (1 Level II, 4 Level III) met the inclusion criteria, including a total of 996 knees undergoing anterior cruciate ligament reconstruction with ST‐QT autograft and 1279 with QT–B autograft. Mean age at surgery ranged from 20.3 to 31.7 years. Minimum follow‐up time ranged from 12.0 to 24.0 months. The overall percentage of men ranged from 48.8% to 84.6%. Graft failure ranged from 2.4% to 7.6% of patients in the ST‐QT autograft group and 3.3% to 6.4% in the QT–B autograft group. No study found a significant difference in graft failure rates between the 2 groups. Intraoperative patellar fracture occurred in 2 cases overall, both in the QT–B group. No studies found a significant difference in return to sport between groups. One study found significantly better Knee Injury and Osteoarthritis Outcome Score subscale scores in the ST‐QT group. One study found a significantly greater proportion of ST‐QT patients showing a positive pivot shift postoperatively. No other significant differences were found for the remaining patient‐reported outcomes between groups. Conclusions: Current comparative evidence suggests ST‐QT and QT–B autografts for primary anterior cruciate ligament reconstruction yield similar short‐ to midterm outcomes, though limited studies and follow‐up warrant cautious interpretation. Patellar fracture remains an uncommon QT–B risk. Level of Evidence: Level III, systematic review of Level II and III studies.
- 29 October 2026
- Published by Wiley in Arthroscopy
Quadriceps Tendon Autograft for Primary Anterior Cruciate Ligament Reconstruction Has No Difference in Short‐Term Clinical Outcomes Between All‐Soft Tissue Versus Tendon–Bone Grafts: A Systematic Review
Purpose: To compare clinical outcomes and complications after primary anterior cruciate ligament reconstruction with all‐soft tissue quadriceps tendon (ST‐QT) versus quadriceps tendon‐bone (QT–B) autograft. Methods: A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines by searching PubMed, Embase, and Cochrane Library to identify studies directly comparing outcomes of primary anterior cruciate ligament reconstruction with ST‐QT versus QT–B autograft. Outcomes included rates of graft failure and other complications, patient‐reported outcomes, return to sport, anteroposterior knee laxity, pivot shift testing, and the Objective International Knee Documentation Committee score. Results: Five studies (1 Level II, 4 Level III) met the inclusion criteria, including a total of 996 knees undergoing anterior cruciate ligament reconstruction with ST‐QT autograft and 1279 with QT–B autograft. Mean age at surgery ranged from 20.3 to 31.7 years. Minimum follow‐up time ranged from 12.0 to 24.0 months. The overall percentage of men ranged from 48.8% to 84.6%. Graft failure ranged from 2.4% to 7.6% of patients in the ST‐QT autograft group and 3.3% to 6.4% in the QT–B autograft group. No study found a significant difference in graft failure rates between the 2 groups. Intraoperative patellar fracture occurred in 2 cases overall, both in the QT–B group. No studies found a significant difference in return to sport between groups. One study found significantly better Knee Injury and Osteoarthritis Outcome Score subscale scores in the ST‐QT group. One study found a significantly greater proportion of ST‐QT patients showing a positive pivot shift postoperatively. No other significant differences were found for the remaining patient‐reported outcomes between groups. Conclusions: Current comparative evidence suggests ST‐QT and QT–B autografts for primary anterior cruciate ligament reconstruction yield similar short‐ to midterm outcomes, though limited studies and follow‐up warrant cautious interpretation. Patellar fracture remains an uncommon QT–B risk. Level of Evidence: Level III, systematic review of Level II and III studies.
- Open Access
- 22 August 2026
- Published by Wiley in Orthopaedic Surgery
- Vol. 18 (10) , 2083-2089
Body Mass Index Modifies the Effect of Hemovac Drainage on Blood Loss After Total Knee Arthroplasty
Objectives: The role of Hemovac drainage after TKA remains uncertain in the tranexamic acid (TXA) era, particularly across patient subgroups. This study investigated whether body mass index (BMI) modifies the association between drainage use and blood loss in patients undergoing TKA. Methods: This retrospective cohort study compared 201 TKA patients divided into a drain group ( n = 101) and a non‐drain group ( n = 100). All procedures incorporated standardized intravenous and intra‐articular administration of tranexamic acid. Primary outcomes included hemoglobin (Hb), hematocrit (Hct), erythrocyte count, and estimated blood loss (EBL). Secondary outcomes were hospital stay duration, knee range of motion, and complications. Between‐group comparisons were performed using independent‐samples t ‐tests and chi‐squared tests, and multiple linear regression assessed the interaction between BMI and drain use on EBL. Results: No significant between‐group differences were observed in Hb, Hct, or erythrocyte count at baseline or on postoperative Day 1. In patients with BMI ≥ 25 kg/m 2 , EBL was significantly lower in the drain group compared to the non‐drain group ( p = 0.044). Regression analysis revealed a significant interaction between drain use and BMI ( p = 0.013). Patients without drains showed an increase in EBL with BMI, whereas the drain group demonstrated a relatively flat relationship. Secondary outcomes were comparable between groups. Conclusion: Hemovac drains were associated with modestly lower EBL in patients with BMI ≥ 25 kg/m 2 undergoing TKA. No differences in clinical outcomes were observed. These findings suggest that the effect of drainage may vary across patient subgroups and support a more individualized approach.
- 22 August 2026
- Published by Wiley in Orthopaedic Surgery
- Vol. 18 (10) , 2083-2089
Open AccessBody Mass Index Modifies the Effect of Hemovac Drainage on Blood Loss After Total Knee Arthroplasty
Objectives: The role of Hemovac drainage after TKA remains uncertain in the tranexamic acid (TXA) era, particularly across patient subgroups. This study investigated whether body mass index (BMI) modifies the association between drainage use and blood loss in patients undergoing TKA. Methods: This retrospective cohort study compared 201 TKA patients divided into a drain group ( n = 101) and a non‐drain group ( n = 100). All procedures incorporated standardized intravenous and intra‐articular administration of tranexamic acid. Primary outcomes included hemoglobin (Hb), hematocrit (Hct), erythrocyte count, and estimated blood loss (EBL). Secondary outcomes were hospital stay duration, knee range of motion, and complications. Between‐group comparisons were performed using independent‐samples t ‐tests and chi‐squared tests, and multiple linear regression assessed the interaction between BMI and drain use on EBL. Results: No significant between‐group differences were observed in Hb, Hct, or erythrocyte count at baseline or on postoperative Day 1. In patients with BMI ≥ 25 kg/m 2 , EBL was significantly lower in the drain group compared to the non‐drain group ( p = 0.044). Regression analysis revealed a significant interaction between drain use and BMI ( p = 0.013). Patients without drains showed an increase in EBL with BMI, whereas the drain group demonstrated a relatively flat relationship. Secondary outcomes were comparable between groups. Conclusion: Hemovac drains were associated with modestly lower EBL in patients with BMI ≥ 25 kg/m 2 undergoing TKA. No differences in clinical outcomes were observed. These findings suggest that the effect of drainage may vary across patient subgroups and support a more individualized approach.
- 12 August 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 134 (6) , 927-938
Immunotherapy in the Treatment of Soft Tissue Sarcoma Since SARC028: An NCDB Analysis
Background: The publication of SARC028 in late 2017 revolutionized soft tissue sarcoma (STS) treatment by demonstrating promising response to anti‐PD1 immunotherapy in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS). Data on immunotherapy efficacy and outcomes in larger cohorts and with longer follow‐up remain limited. Methods: 31 672 cases of UPS, DDLPS, alveolar soft part sarcoma, and myxofibrosarcoma were extracted from the NCDB. Factors associated with the use of immunotherapy were evaluated using logistic regression, and survival analysis was performed with Kaplan‐Meier curves and Cox proportional hazards models. Results: Patients diagnosed with STS after 2017 were 3.67 times more likely to receive immunotherapy. Immunotherapy was associated with an approximately 20% reduction in mortality in stage IV STS, which was driven by cases of UPS. This survival benefit was observed in male, but not female, patients. There was no survival benefit in stage III STS. Discussion: These data are consistent with a survival benefit with immunotherapy in stage IV STS, predominantly in UPS, supporting the findings of SARC028. Benefit in stage III STS was not observed, limiting concordance with later trials like SARC032. Further prospective data on long‐term outcomes and immunotherapy efficacy according to histology and sex are needed.
- 12 August 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 134 (6) , 927-938
Immunotherapy in the Treatment of Soft Tissue Sarcoma Since SARC028: An NCDB Analysis
Background: The publication of SARC028 in late 2017 revolutionized soft tissue sarcoma (STS) treatment by demonstrating promising response to anti‐PD1 immunotherapy in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS). Data on immunotherapy efficacy and outcomes in larger cohorts and with longer follow‐up remain limited. Methods: 31 672 cases of UPS, DDLPS, alveolar soft part sarcoma, and myxofibrosarcoma were extracted from the NCDB. Factors associated with the use of immunotherapy were evaluated using logistic regression, and survival analysis was performed with Kaplan‐Meier curves and Cox proportional hazards models. Results: Patients diagnosed with STS after 2017 were 3.67 times more likely to receive immunotherapy. Immunotherapy was associated with an approximately 20% reduction in mortality in stage IV STS, which was driven by cases of UPS. This survival benefit was observed in male, but not female, patients. There was no survival benefit in stage III STS. Discussion: These data are consistent with a survival benefit with immunotherapy in stage IV STS, predominantly in UPS, supporting the findings of SARC028. Benefit in stage III STS was not observed, limiting concordance with later trials like SARC032. Further prospective data on long‐term outcomes and immunotherapy efficacy according to histology and sex are needed.
- Open Access
- 28 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5042
Effects of GLP-1 Receptor Agonists on Breast Reconstruction Outcomes: A Large-Database Retrospective Study
Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for diabetes and weight loss, with many breast reconstruction candidates being prescribed these medications. However, perioperative risks remain unclear. This study evaluated the association between GLP-1RA use and postoperative complications in implant-based and autologous tissue breast reconstruction. Methods: A retrospective analysis of TriNetX identified patients undergoing implant-based or autologous tissue breast reconstruction. Preoperative GLP-1RA users were compared to matched controls. Patients were propensity score matched (1:1 and 1:3) for demographics and comorbidities including body-mass index and timing of reconstruction (delayed vs. immediate). Ninety-day outcomes were assessed using logistic regression. Results: Between 2014 and 2024, 57,987 patients were identified, of which 823 were GLP-1RA users. Of those users, 326 patients undergoing implant-based reconstruction and 51 patients undergoing autologous reconstruction were matched to controls. In implant-based cohorts, GLP-1RA use was associated with increased odds of implant failure (1:1 OR 1.70, 95% CI 1.18–2.45, p = 0.0046), wound healing complications (1:1 OR 1.90, p = 0.027), and higher readmission/ED utilization (1:1 OR 1.80, 95% CI 1.04–3.21, p = 0.040). No significant differences were observed for hematoma, seroma, or thromboembolism. In autologous reconstruction, GLP-1RA use was not associated with increased risks. Conclusions: GLP-1RA use is linked to higher rates of implant failure, wound healing complications, and readmission in implant-based breast reconstruction only. These findings highlight the need for risk stratification and counseling of GLP-1RA users undergoing implant-based procedures and for further research investigating the implications of perioperative use of these agents in plastic surgery.
- 28 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5042
Open AccessEffects of GLP-1 Receptor Agonists on Breast Reconstruction Outcomes: A Large-Database Retrospective Study
Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for diabetes and weight loss, with many breast reconstruction candidates being prescribed these medications. However, perioperative risks remain unclear. This study evaluated the association between GLP-1RA use and postoperative complications in implant-based and autologous tissue breast reconstruction. Methods: A retrospective analysis of TriNetX identified patients undergoing implant-based or autologous tissue breast reconstruction. Preoperative GLP-1RA users were compared to matched controls. Patients were propensity score matched (1:1 and 1:3) for demographics and comorbidities including body-mass index and timing of reconstruction (delayed vs. immediate). Ninety-day outcomes were assessed using logistic regression. Results: Between 2014 and 2024, 57,987 patients were identified, of which 823 were GLP-1RA users. Of those users, 326 patients undergoing implant-based reconstruction and 51 patients undergoing autologous reconstruction were matched to controls. In implant-based cohorts, GLP-1RA use was associated with increased odds of implant failure (1:1 OR 1.70, 95% CI 1.18–2.45, p = 0.0046), wound healing complications (1:1 OR 1.90, p = 0.027), and higher readmission/ED utilization (1:1 OR 1.80, 95% CI 1.04–3.21, p = 0.040). No significant differences were observed for hematoma, seroma, or thromboembolism. In autologous reconstruction, GLP-1RA use was not associated with increased risks. Conclusions: GLP-1RA use is linked to higher rates of implant failure, wound healing complications, and readmission in implant-based breast reconstruction only. These findings highlight the need for risk stratification and counseling of GLP-1RA users undergoing implant-based procedures and for further research investigating the implications of perioperative use of these agents in plastic surgery.
- Open Access
- 1 April 2026
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 11 (2)
Exploring the Orthopaedic Surgery Match
Introduction: Orthopaedic Surgery remains one of the most competitive medical specialties to successfully match into. Historically, the United States Medical Licensing Examination Step 1 score was a major determinant of match success. Since its conversion to pass/fail status in January 2022, uncertainty has emerged regarding how programs mentor and advise applicants. The purpose of this study was to examine the changes in Orthopaedic Surgery applicant characteristics before the transition from a scored examination (2017-2022) to a pass/fail examination (2023-2025). Methods: The authors accessed the Texas Seeking Transparency in Application to Residency survey database, which contains survey information from graduating medical students nationwide regarding residency application characteristics. Characteristics of matched versus unmatched applicants between 2017 to 2022 and 2023 to 2025 were compared. Results: A total of 1,652 Orthopaedic Surgery applicants responded to the survey from 2017 to 2025 (data collected in May 2025). Since the incorporation of a pass/fail Step 1, Step 2 scores and research productivity has increased, volunteerism has decreased, and other academic metrics have remained unchanged. Conclusions: Applicants demonstrated shifts in characteristics without a corresponding change in match rates. From 2023 to 2025, applicants bolstered Step 2 performance and research output as primary differentiators in the absence of a numerical Step 1 score. Traditional academic markers such as class rank, clerkship performance, and Alpha Omega Alpha membership remained stable, while volunteer and leadership involvement declined moderately over the same period. These findings provide evidence-based guidance for navigating the Orthopaedic Surgery selection process in the postnumerical Step 1 era.
- 1 April 2026
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 11 (2)
Open AccessExploring the Orthopaedic Surgery Match
Introduction: Orthopaedic Surgery remains one of the most competitive medical specialties to successfully match into. Historically, the United States Medical Licensing Examination Step 1 score was a major determinant of match success. Since its conversion to pass/fail status in January 2022, uncertainty has emerged regarding how programs mentor and advise applicants. The purpose of this study was to examine the changes in Orthopaedic Surgery applicant characteristics before the transition from a scored examination (2017-2022) to a pass/fail examination (2023-2025). Methods: The authors accessed the Texas Seeking Transparency in Application to Residency survey database, which contains survey information from graduating medical students nationwide regarding residency application characteristics. Characteristics of matched versus unmatched applicants between 2017 to 2022 and 2023 to 2025 were compared. Results: A total of 1,652 Orthopaedic Surgery applicants responded to the survey from 2017 to 2025 (data collected in May 2025). Since the incorporation of a pass/fail Step 1, Step 2 scores and research productivity has increased, volunteerism has decreased, and other academic metrics have remained unchanged. Conclusions: Applicants demonstrated shifts in characteristics without a corresponding change in match rates. From 2023 to 2025, applicants bolstered Step 2 performance and research output as primary differentiators in the absence of a numerical Step 1 score. Traditional academic markers such as class rank, clerkship performance, and Alpha Omega Alpha membership remained stable, while volunteer and leadership involvement declined moderately over the same period. These findings provide evidence-based guidance for navigating the Orthopaedic Surgery selection process in the postnumerical Step 1 era.
- Open Access
- 19 December 2025
- Published by Elsevier in Journal of Orthopaedic Reports
- Vol. 5 (4)
Profiling the cellular response to allogeneic mesenchymal stromal cells implantation in acute and non-union calvarial defects in mice
- 19 December 2025
- Published by Elsevier in Journal of Orthopaedic Reports
- Vol. 5 (4)
Open AccessProfiling the cellular response to allogeneic mesenchymal stromal cells implantation in acute and non-union calvarial defects in mice
- Open Access
- 5 December 2025
- Published by Associacao Brasileira de Medicina e Cirurgia do Tornozelo e Pe (ABTPe) in Journal of the Foot & Ankle
- Vol. 19 (3) , 6
Lateral column lengthening: A cadaveric biomechanical study
Objective: This cadaveric biomechanical study aimed to investigate the potential cause of the subtalar joint impingement after lateral column lengthening (LCL). Methods: Eight fresh-frozen cadaveric feet underwent sequential LCL osteotomy with grafts of 6 mm, 8 mm, 10 mm, and 12 mm. Uniplanar motion analysis tracked anterior and posterior fragment movements. Mixed linear regression was used to assess correlations between graft size and fragment displacement. Results: During LCL, the anterior fragment shifted anteriorly while the posterior fragment shifted posteriorly, with the anterior shift being greater than the posterior shift. From 6 mm to 12 mm of lengthening, the amount of posterior shift per millimeter peaked at 8 mm of lengthening and then decreased. A linear regression relationship was detected between the amount of lengthening and the anterior shift, with 1 mm lengthening inducing 1.07 mm anterior shift (p < 0.001). Conclusion: In non-deformed cadaveric feet, LCL not only produced an anterior shift as expected but also induced a posterior shift of the tuberosity. Linear correlation was detected between the size of the lengthening and the anterior shift of the anterior fragment. The posterior shift eventually decreased after the insertion of a large graft (10 mm and 12 mm). The clinical application of these findings to flatfoot deformities remains uncertain and should be validated in future studies. Level of Evidence III.
- 5 December 2025
- Published by Associacao Brasileira de Medicina e Cirurgia do Tornozelo e Pe (ABTPe) in Journal of the Foot & Ankle
- Vol. 19 (3) , 6
Open AccessLateral column lengthening: A cadaveric biomechanical study
Objective: This cadaveric biomechanical study aimed to investigate the potential cause of the subtalar joint impingement after lateral column lengthening (LCL). Methods: Eight fresh-frozen cadaveric feet underwent sequential LCL osteotomy with grafts of 6 mm, 8 mm, 10 mm, and 12 mm. Uniplanar motion analysis tracked anterior and posterior fragment movements. Mixed linear regression was used to assess correlations between graft size and fragment displacement. Results: During LCL, the anterior fragment shifted anteriorly while the posterior fragment shifted posteriorly, with the anterior shift being greater than the posterior shift. From 6 mm to 12 mm of lengthening, the amount of posterior shift per millimeter peaked at 8 mm of lengthening and then decreased. A linear regression relationship was detected between the amount of lengthening and the anterior shift, with 1 mm lengthening inducing 1.07 mm anterior shift (p < 0.001). Conclusion: In non-deformed cadaveric feet, LCL not only produced an anterior shift as expected but also induced a posterior shift of the tuberosity. Linear correlation was detected between the size of the lengthening and the anterior shift of the anterior fragment. The posterior shift eventually decreased after the insertion of a large graft (10 mm and 12 mm). The clinical application of these findings to flatfoot deformities remains uncertain and should be validated in future studies. Level of Evidence III.
- Open Access
- 25 November 2025
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics
- Vol. 46 (6) , e535-e541
Hip Abduction Brace Is an Effective Treatment Alternative for Femur Fractures in Infants 12 Months and Younger
Background: Femur fractures in infants ≤12 months are rare but significant injuries. Traditional methods of immobilization such as the Pavlik harness and spica cast have limitations related to fracture stability, comfort, and caregiver burden. The hip abduction brace (HAB), widely used for developmental dysplasia of the hip (DDH) treatment, has not been well-studied for infant femur fracture management. This study evaluated the efficacy of the HAB compared with the Pavlik harness and spica cast in infants ≤12 months with femur fractures. Methods: Following IRB approval, we conducted a retrospective cohort study of infants ≤12 months with proximal or diaphyseal femur fractures at our level one pediatric hospital trauma center from 2013 to 2024. Patients were categorized by treatment method (Pavlik harness, HAB, or spica cast) and analyzed in 2 groups at age of injury: ≤6.99 months (group A) or 7 to 12.99 months (group B). Demographic, clinical, and radiographic data was collected. The primary outcome was residual fracture angulation at final follow-up. Comparisons between treatment groups used linear mixed models, ANOVA, and χ 2 tests (α=0.05). Results: A total of 143 patients (148 fractures) were included. Overall mean age was 5.15 months at the time of injury (2.82±2.00 mo in group A, 9.36±1.65 mo in group B). Seventy-four fractures were treated with the Pavlik harness, 48 with Spica cast, and 22 with the HAB. Four fractures treated with a splint were excluded from this analysis. Initial imaging showed no statistical differences in initial angulation, fracture pattern, or fracture location between the treatment groups. While numerical data showed lower residual lateral angulation in the HAB group following treatment, there were overall no significant differences between treatment groups in both group A and group B. Femoral nerve palsy occurred in 10.3% of Pavlik-treated infants ≤6 months, but no complications were noted in the HAB or spica cast groups. Conclusions: In this large cohort study of infants ≤12 months with proximal or diaphyseal femur fractures, treatment with a hip abduction brace (HAB) resulted in radiographic outcomes that were equivalent to the Pavlik harness and spica cast, without any major complications. The HAB is an effective and practical treatment for infant femur fracture. Level of Evidence: Level III—therapeutic study: retrospective comparative study.
- 25 November 2025
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics
- Vol. 46 (6) , e535-e541
Open AccessHip Abduction Brace Is an Effective Treatment Alternative for Femur Fractures in Infants 12 Months and Younger
Background: Femur fractures in infants ≤12 months are rare but significant injuries. Traditional methods of immobilization such as the Pavlik harness and spica cast have limitations related to fracture stability, comfort, and caregiver burden. The hip abduction brace (HAB), widely used for developmental dysplasia of the hip (DDH) treatment, has not been well-studied for infant femur fracture management. This study evaluated the efficacy of the HAB compared with the Pavlik harness and spica cast in infants ≤12 months with femur fractures. Methods: Following IRB approval, we conducted a retrospective cohort study of infants ≤12 months with proximal or diaphyseal femur fractures at our level one pediatric hospital trauma center from 2013 to 2024. Patients were categorized by treatment method (Pavlik harness, HAB, or spica cast) and analyzed in 2 groups at age of injury: ≤6.99 months (group A) or 7 to 12.99 months (group B). Demographic, clinical, and radiographic data was collected. The primary outcome was residual fracture angulation at final follow-up. Comparisons between treatment groups used linear mixed models, ANOVA, and χ 2 tests (α=0.05). Results: A total of 143 patients (148 fractures) were included. Overall mean age was 5.15 months at the time of injury (2.82±2.00 mo in group A, 9.36±1.65 mo in group B). Seventy-four fractures were treated with the Pavlik harness, 48 with Spica cast, and 22 with the HAB. Four fractures treated with a splint were excluded from this analysis. Initial imaging showed no statistical differences in initial angulation, fracture pattern, or fracture location between the treatment groups. While numerical data showed lower residual lateral angulation in the HAB group following treatment, there were overall no significant differences between treatment groups in both group A and group B. Femoral nerve palsy occurred in 10.3% of Pavlik-treated infants ≤6 months, but no complications were noted in the HAB or spica cast groups. Conclusions: In this large cohort study of infants ≤12 months with proximal or diaphyseal femur fractures, treatment with a hip abduction brace (HAB) resulted in radiographic outcomes that were equivalent to the Pavlik harness and spica cast, without any major complications. The HAB is an effective and practical treatment for infant femur fracture. Level of Evidence: Level III—therapeutic study: retrospective comparative study.
- Open Access
- 14 October 2025
- Published by MDPI AG in Journal of Imaging
- Vol. 11 (10) , 363
Radiographic Markers of Hip Dysplasia and Femoroacetabular Impingement Are Associated with Deterioration in Acetabular and Femoral Cartilage Quality: Insights from T2 MRI Mapping
Femoroacetabular impingement (FAI) and hip dysplasia have been shown to increase the risk of hip osteoarthritis in affected individuals. MRI with T2 mapping provides an objective measure of femoral and acetabular articular cartilage tissue quality. This study aims to evaluate the relationship between hip morphology measurements collected from three-dimensional (3D) reconstructed computed tomography (CT) scans and the T2 mapping values of hip articular cartilage assessed by three independent, blinded reviewers on the optimal sagittal cut. Hip morphology measures including lateral center edge angle (LCEA), acetabular version, Tönnis angle, acetabular coverage, alpha angle, femoral torsion, neck-shaft angle (FNSA), and combined version were recorded from preoperative CT scans. The relationship between T2 values and hip morphology was assessed using univariate linear mixed models with random effects for individual patients. Significant associations were observed between femoral and acetabular articular cartilage T2 values and all hip morphology measures except femoral torsion. Hip morphology measurements consistent with dysplastic anatomy including decreased LCEA, increased Tönnis angle, and decreased acetabular coverage were associated with increased cartilage damage (p < 0.001 for all). Articular cartilage T2 values were strongly associated with the radiographic markers of hip dysplasia, suggesting hip microinstability significantly contributes to cartilage damage. The relationships between hip morphology measurements and T2 values were similar for the femoral and acetabular sides, indicating that damage to both surfaces is comparable rather than preferentially affecting one side.
- 14 October 2025
- Published by MDPI AG in Journal of Imaging
- Vol. 11 (10) , 363
Open AccessRadiographic Markers of Hip Dysplasia and Femoroacetabular Impingement Are Associated with Deterioration in Acetabular and Femoral Cartilage Quality: Insights from T2 MRI Mapping
Femoroacetabular impingement (FAI) and hip dysplasia have been shown to increase the risk of hip osteoarthritis in affected individuals. MRI with T2 mapping provides an objective measure of femoral and acetabular articular cartilage tissue quality. This study aims to evaluate the relationship between hip morphology measurements collected from three-dimensional (3D) reconstructed computed tomography (CT) scans and the T2 mapping values of hip articular cartilage assessed by three independent, blinded reviewers on the optimal sagittal cut. Hip morphology measures including lateral center edge angle (LCEA), acetabular version, Tönnis angle, acetabular coverage, alpha angle, femoral torsion, neck-shaft angle (FNSA), and combined version were recorded from preoperative CT scans. The relationship between T2 values and hip morphology was assessed using univariate linear mixed models with random effects for individual patients. Significant associations were observed between femoral and acetabular articular cartilage T2 values and all hip morphology measures except femoral torsion. Hip morphology measurements consistent with dysplastic anatomy including decreased LCEA, increased Tönnis angle, and decreased acetabular coverage were associated with increased cartilage damage (p < 0.001 for all). Articular cartilage T2 values were strongly associated with the radiographic markers of hip dysplasia, suggesting hip microinstability significantly contributes to cartilage damage. The relationships between hip morphology measurements and T2 values were similar for the femoral and acetabular sides, indicating that damage to both surfaces is comparable rather than preferentially affecting one side.
- 3 September 2025
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics
- Vol. 46 (2) , e164-e171
Severe Cerebral Palsy and Short Stature Predict Absent Baseline IONM Signals in Pediatric Neuromuscular Scoliosis Surgery
Background: Intraoperative neurophysiological monitoring (IONM) is essential for detecting potential neurological injury during scoliosis surgery, but obtaining recordable baseline signals can be challenging in neuromuscular scoliosis (NMS) patients. Absent baseline IONM signals, characterized by unattainable initial IONM responses despite technical and anesthetic optimization, present significant challenges to intraoperative neurological assessment and surgical risk stratification. This study aims to identify predictive factors for absent baseline IONM signals in pediatric NMS patients and establish a clinically applicable risk prediction model. Methods: This retrospective study initially identified 118 nonambulatory NMS patients under 18 years old who underwent spinopelvic fusion between 2013 and 2022. All patients received standardized total intravenous anesthesia (TIVA) protocol to optimize signal acquisition. After excluding 3 patients with spinal cord injuries, 115 patients were analyzed. Multimodality IONM, including somatosensory evoked potentials (SSEPs) and transcranial electrical motor evoked potentials (TcMEPs) was attempted in all cases. Clinical data and radiographic measurements were analyzed to determine predictive factors for absent baseline IONM signal. ROC curve analysis and logistic regression were used to determine optimal thresholds and predictive factors for absent baseline IONM signals. Results: Thirty-eight (33%) had absent baseline lower extremity IONM signals. Cerebral palsy (CP) was the most significant predictive factor [odds ratio (OR): 9.615, P P =0.028) and body height P =0.044) were significant risk factors. Three patients developed new-onset urinary incontinence postoperatively, though the relationship to IONM status remains undetermined. Conclusion: Severe CP and shorter stature significantly increase the risk of absent baseline IONM signals in pediatric NMS patients. These findings inform preoperative risk assessment, enhance patient-specific surgical planning, and suggest the need for alternative monitoring approaches in high-risk cases. Such early identification of monitoring challenges can improve surgical preparation, consent processes, and ultimately patient care in this vulnerable population. Level of Evidence: Level III.
- 3 September 2025
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics
- Vol. 46 (2) , e164-e171
Severe Cerebral Palsy and Short Stature Predict Absent Baseline IONM Signals in Pediatric Neuromuscular Scoliosis Surgery
Background: Intraoperative neurophysiological monitoring (IONM) is essential for detecting potential neurological injury during scoliosis surgery, but obtaining recordable baseline signals can be challenging in neuromuscular scoliosis (NMS) patients. Absent baseline IONM signals, characterized by unattainable initial IONM responses despite technical and anesthetic optimization, present significant challenges to intraoperative neurological assessment and surgical risk stratification. This study aims to identify predictive factors for absent baseline IONM signals in pediatric NMS patients and establish a clinically applicable risk prediction model. Methods: This retrospective study initially identified 118 nonambulatory NMS patients under 18 years old who underwent spinopelvic fusion between 2013 and 2022. All patients received standardized total intravenous anesthesia (TIVA) protocol to optimize signal acquisition. After excluding 3 patients with spinal cord injuries, 115 patients were analyzed. Multimodality IONM, including somatosensory evoked potentials (SSEPs) and transcranial electrical motor evoked potentials (TcMEPs) was attempted in all cases. Clinical data and radiographic measurements were analyzed to determine predictive factors for absent baseline IONM signal. ROC curve analysis and logistic regression were used to determine optimal thresholds and predictive factors for absent baseline IONM signals. Results: Thirty-eight (33%) had absent baseline lower extremity IONM signals. Cerebral palsy (CP) was the most significant predictive factor [odds ratio (OR): 9.615, P P =0.028) and body height P =0.044) were significant risk factors. Three patients developed new-onset urinary incontinence postoperatively, though the relationship to IONM status remains undetermined. Conclusion: Severe CP and shorter stature significantly increase the risk of absent baseline IONM signals in pediatric NMS patients. These findings inform preoperative risk assessment, enhance patient-specific surgical planning, and suggest the need for alternative monitoring approaches in high-risk cases. Such early identification of monitoring challenges can improve surgical preparation, consent processes, and ultimately patient care in this vulnerable population. Level of Evidence: Level III.